The Medicare Advantage market is entering a new phase defined by slower growth, financial retrenchment, and heightened operational discipline. We discuss key takeaways for providers.
As Medicare Advantage recalibrates, both payers and providers are reassessing how to sustain performance and profitability amid tightening margins and evolving CMS standards.
Regulatory disruptions and increased venture capital funding for AI-enabled digital health startups reflect the healthcare industry’s growing adoption of AI tools.
The rate increase comes alongside a revised risk adjustment model. The effects of these changes on the healthcare ecosystem remain to be seen, particularly on access and quality.
Our 2025 Medicare Advantage competitive enrollment report analyzes decelerating growth as the market undergoes a period of correction. We discuss six key trends and action items for health plans.
Amid regulatory uncertainty, Medicare Advantage leaders’ priorities reveal a focus on weathering recent disruption, with an eye toward a more favorable forecast for the coming year.
Substance use disorder (SUD) platforms that provide care across the continuum can have tremendous impact. We discuss three essential goals and the related areas on which SUD providers need to focus.
Funding reports demonstrate the resilience and adaptability of digital health and suggest new venture patterns. But the sector will need to closely monitor and adapt to evolving regulations.
